Where does big Pharma spend a bit of big change? Here's one example. BD
Four Big Pharma companies spent some serious cash to lobby congress in the second quarter of 2008. A common concern was legislation that would allow FDA to approve less-expensive generic versions of biotech drugs, as was a bill to update the U.S. patent system (the latter remains stalled in the Senate). Likewise, implementation of Medicare drug benefits for seniors was a hot topic.
Bristol-Myers Squibb spent $830,000, Amgen spent nearly $2.9 million, Abbott Labs, which makes drugs and medical devices, spent more than $1 million, AstraZeneca spent more than $1.3 million.
0 comments :
Post a Comment